We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Valeant’s access program with Walgreens, which the company says will make the company’s products affordable, is slated to kick off this Friday with dermatology brands, according to Ari Kellen, executive vice president and company group chairman. Read More
While 2014 and 2015 were years of megamergers in the pharmaceutical industry, a new report predicts that 2016 will give rise to a rather different competitive landscape, one where bigger is not necessarily better. Read More
The U.S. Supreme Court delivered Janssen a stinging rebuke on Monday, declining to hear its appeal of a $124 million penalty ordered by the Supreme Court of South Carolina over claims of deceptive advertising. Read More
A California supplement maker is in hot water after being accused of making drug-like claims about its products and relying on improper production methods. Read More
Drugmarkers are reporting a 20 percent improvement in securing their supply chains compared with a year ago, according to findings from a new report. Read More
Two House members are asking two embattled drugmakers for information and documents related to some of their products ahead of a Jan. 26 hearing on prescription drug pricing. Read More